Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.
published in: Journal of Clinical Oncology
date of publication: 2017-10-09
language: English
main subject: metastatic melanoma
Cites articles
There is nothing here
Article - wd:Q46793681